Manchester Royal Eye Hospital
Manchester, M13 9WL, United Kingdom
NCT Number: NCT02585063
The UK government's Crown report titled 'Review of prescribing, supply & administration of medicines' enabled optometrists to train for the qualification of independent prescribing (IP). The UK introduced IP for optometrists in 2009. The proposed research focuses on the role of IP optometrist in the acute ophthalmic services of Manchester Royal Eye Hospital (MREH). The study will compare IP optometrists to consultant ophthalmologists in the ability to diagnose, manage and prescribe medication for patients accessing these services.
To achieve this comparison consenting participants will first have a clinical assessment with the IP Optometrist, where findings including diagnosis and management plan will be recorded onto a research proforma. The consultant ophthalmologist will be masked to the IP Optometrist's research proforma to prevent bias. The consultant ophthalmologist will then perform a clinical assessment on a second proforma and inform the participant of their diagnosis and management plan. Percentage agreement, kappa (κ) and weighted κ will be calculated for a range of parameters between the two proformas. Disagreement in diagnosis or management will be arbitrated by a separate ophthalmologist participating in the study with a specialty relevant to the participant's condition.
The main objective of the research is to expand the limited base of evidence of of IP optometrists' ability to diagnose, manage and prescribe medication and to determine whether they work at least as safely and effectively as consultant ophthalmologists in acute ophthalmic services. It is the first study in this area since the advent of IP for optometrists, with only one previous study published before IP was introduced. The research will enable the type and frequency of conditions presenting in these services to be measured. Furthermore it will identify conditions that IP optometrists can manage independently and enable guidelines for these conditions to be developed.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Manchester, M13 9WL, United Kingdom
What are the purpose and objectives of the research?
The primary aim of this prospective, masked, controlled comparative study is to measure the agreement in diagnosis between IP optometrists and the reference standard of consultant ophthalmologists.
A secondary aim is to measure agreement in management of the diagnosis, including the decision whether or not to prescribe medication. The choice of not prescribing medication is an important prescribing decision and will be counted as such. This measure is the novel aspect of the research as it provides evidence of IP optometrists' ability to safely prescribe.
What is the scientific justification for the research?
The NHS's emergency services are experiencing increasing demand (Ismail et al 2013), which is also true of MREH's Acute Referral Centre where IP optometrists work as part of a multidisciplinary team. There is a scientific need to provide an evidence base to validate and support the role of optometrists working in acute ophthalmic services, as well as provide evidence of IP optometrist's ability to safely prescribe medication. This evidence base may in turn lend support to nationally extending the role of IP Optometrists' and their skills to the benefit of the Health Service. Establishing an audit meets the clinic need to monitor performance of IP optometrists working in this extended role. Guidelines for IP optometrists working within MREH Acute Ophthalmic Services offer a way to optimise the running of the clinic as patient can be triaged to clinicians and ophthalmologists feed to see complex cases.
A novel aspect of this study is that it will compare optometrists' management decisions involving the prescribing of ocular medication since IP was introduced (General Optical Council 2014). There is no evidence of studies into the safety of such prescribing decisions by IP optometrists in acute ophthalmic care. Hau et al (2007) study entitled 'An evaluation of optometrists' ability to correctly identify and manage patient s with ocular disease in the accident and emergency department of an eye hospital' was before the introduction of IP.
Duration
The study will begin in Summer 2015, pending ethics approval, and will last for 18 months.
Sample size
A sample of up to 1500 may be achieved based on 20 participants per week over a period of 18 months. This breaks down to 2.5 participants per study session. It is anticipated that the principal IP optometrist of the Acute Referral clinic who works there 4 sessions a week will have the potential to perform ~690 clinical assessments for the study. The remaining three IP optometrists who work one session a week will have the potential to perform ~172 clinical assessments.
A sample size of 500 with disagreement on diagnosis in 15 individuals is required to give a target disagreement rate of 3.0% (binomial 95% CI 1.7-4.9%). The larger anticipated sample size will ensure that at least 500 are available where a prescribing decision has been made, whilst maintaining small binomial confidence intervals.
Method
The protocol for the study is as follows:
Willingness to participate may depend on the individual and their presenting complaint. It may be expected that someone with severe symptoms who is triaged to be seen more urgently would be less inclined to have two clinical assessments. Analysis of the presenting complaints may identify trends in the severity versus participation in the study. It will be made clear that there is no obligation to participate and that if people do decide to take part that they can withdraw at any time.
Sessions where a Consultant Ophthalmologist is in ARC will be allocated as a 'study session'. The study sessions will need to be allocated to ensure that approximately equal numbers of patients will be seen by the participating IP Optometrists. Consultant ophthalmologists with various specialties work with IP optometrists across 8 half day clinics during the week. A limitation of collecting data from these set times is that if there are conditions specific to presenting on an evening or weekend they will not be sampled representatively. Whilst this restricts analysis of certain conditions it ensures the focus of the study, evaluation of management by IP Optometrists to be achieved.
A pragmatic approach will be required for the recruitment of patients into the study given organisational issues or limited time and rooms available to see patients. The recruitment per session for the comparative arm of the study can be capped by the Ophthalmologist within the clinic. Allowing a cap ensures that waiting times are kept within reason and the level of care is maintained. The cap risks introducing selection bias as potential participants presenting to clinic early may be more likely to be have the two comparative clinical assessments. The time of attendance in clinic will be recorded to monitor if this happens.
The consultation will be documented on the study proforma and include the following:
The assessment is expected to lead to the formation of a working diagnosis and management plan including the following where appropriate; prescribing ophthalmic medication, follow-up, referral or discharge. The proforma will have boxes to record diagnosis (primary and secondary where appropriate), management plan, treatment (including strength and dosing regimen), advice to patient and in addition a comments box to permit a judgment on whether the case could have been managed solely by an IP Optometrist. There may be occasions where conditions present outside of the scope of the IP Optometrists experience, which will be recorded in the comments box noting any reasons for this.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: Through study completion - up to 18 months
The prescribing decisions of ophthalmologists and optometrists will be compared. They will be documented via self-reports.
Aston University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03578302
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
New York, United States
View Trial DetailsNCT06733428
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Chicago, Illinois, United States
View Trial DetailsNCT06004570
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Gdansk, Poland
View Trial DetailsNCT04937725
Ataxia, Ataxia, Cerebellar
Valladolid, Spain
View Trial Details